Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic.

Berget C, Thomas SE, Messer LH, Thivener K, Slover RH, Wadwa RP, Alonso GT.

J Diabetes Sci Technol. 2019 Mar 12:1932296819835183. doi: 10.1177/1932296819835183. [Epub ahead of print]

PMID:
30862242
2.

Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes.

Slover RH, Tryggestad JB, DiMeglio LA, Fox LA, Bode BW, Bailey TS, Brazg R, Christiansen MP, Sherr JL, Tsalikian E, Kaiserman KB, Sullivan A, Huang S, Shin J, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2018 Sep;20(9):576-584. doi: 10.1089/dia.2018.0109. Epub 2018 Jul 31.

PMID:
30063162
3.

Improving the Insulin Pump Initiation Process for Pediatric Patients with Type 1 Diabetes through Application of Lean Quality Improvement Methods.

Alonso GT, Hink R, De Georgeo MR, Vidal K, Thomas S, Swaschnig D, Spiegel G, Owen S, Thurston J, Pyle L, Slover R.

Perm J. 2018;22:17-147. doi: 10.7812/TPP/17-147.

4.

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.

Messer LH, Forlenza GP, Sherr JL, Wadwa RP, Buckingham BA, Weinzimer SA, Maahs DM, Slover RH.

Diabetes Care. 2018 Apr;41(4):789-796. doi: 10.2337/dc17-1682. Epub 2018 Feb 14.

5.

Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor.

Christiansen MP, Garg SK, Brazg R, Bode BW, Bailey TS, Slover RH, Sullivan A, Huang S, Shin J, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2017 Aug;19(8):446-456. doi: 10.1089/dia.2017.0087. Epub 2017 Jul 12.

6.

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.

Messer LH, Forlenza GP, Wadwa RP, Weinzimer SA, Sherr JL, Hood KK, Buckingham BA, Slover RH, Maahs DM.

Pediatr Diabetes. 2018 Feb;19(1):14-17. doi: 10.1111/pedi.12535. Epub 2017 Jun 27. No abstract available.

PMID:
28656656
7.

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR.

Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089/dia.2016.0421. Epub 2017 Jan 30.

8.

A survey of youth with new onset type 1 diabetes: Opportunities to reduce diabetic ketoacidosis.

Baldelli L, Flitter B, Pyle L, Maahs DM, Klingensmith G, Slover R, Alonso GT.

Pediatr Diabetes. 2017 Nov;18(7):547-552. doi: 10.1111/pedi.12455. Epub 2016 Oct 11.

9.

Best Ways and Practices to Avoid Insulin Pump Catheter Occlusions.

Slover RH.

Diabetes Technol Ther. 2016 Mar;18(3):118-9. doi: 10.1089/dia.2016.0025. Epub 2016 Mar 7. No abstract available.

PMID:
26950802
10.

Effects of Frequency of Sensor-Augmented Pump Use on HbA1c and C-Peptide Levels in the First Year of Type 1 Diabetes.

Triolo TM, Maahs DM, Pyle L, Slover R, Buckingham B, Cheng P, DiMeglio LA, Bremer AA, Weinzimer SA, Chase HP; Diabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups.

Diabetes Care. 2016 Apr;39(4):e61-2. doi: 10.2337/dc15-2201. Epub 2016 Feb 19. No abstract available.

11.

Use of Telemedicine to Improve Adherence to American Diabetes Association Standards in Pediatric Type 1 Diabetes.

Wood CL, Clements SA, McFann K, Slover R, Thomas JF, Wadwa RP.

Diabetes Technol Ther. 2016 Jan;18(1):7-14. doi: 10.1089/dia.2015.0123. Epub 2015 Aug 21.

PMID:
26295939
12.

Erratum. Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis. Diabetes Care 2015;38:1197-1204.

Buckingham BA, Raghinaru D, Cameron F, Bequette BW, Chase HP, Maahs DM, Slover R, Wadwa RP, Wilson DM, Ly T, Aye T, Hramiak I, Clarson C, Stein R, Gallego PH, Lum J, Sibayan J, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Care. 2015 Sep;38(9):1813. doi: 10.2337/dc15-er09. No abstract available.

13.

Downloading Diabetes Device Information.

Chase HP, Owen SL, Slover RH.

Diabetes Technol Ther. 2015 Aug;17(8):534-5. doi: 10.1089/dia.2015.0172. Epub 2015 May 20. No abstract available.

PMID:
26237306
14.

Pediatric Headaches.

Slover R, Kent S.

Adv Pediatr. 2015 Aug;62(1):283-93. doi: 10.1016/j.yapd.2015.04.006. Review.

PMID:
26205118
15.

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis.

Buckingham BA, Raghinaru D, Cameron F, Bequette BW, Chase HP, Maahs DM, Slover R, Wadwa RP, Wilson DM, Ly T, Aye T, Hramiak I, Clarson C, Stein R, Gallego PH, Lum J, Sibayan J, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Care. 2015 Jul;38(7):1197-204. doi: 10.2337/dc14-3053. Epub 2015 Jun 6. Erratum in: Diabetes Care. 2015 Sep;38(9):1813.

16.

Incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in Colorado youth, 1998-2012.

Rewers A, Dong F, Slover RH, Klingensmith GJ, Rewers M.

JAMA. 2015 Apr 21;313(15):1570-2. doi: 10.1001/jama.2015.1414. No abstract available.

PMID:
25898057
17.

CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.

Buckingham B, Cheng P, Beck RW, Kollman C, Ruedy KJ, Weinzimer SA, Slover R, Bremer AA, Fuqua J, Tamborlane W; Diabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups.

Diabetologia. 2015 Jun;58(6):1167-74. doi: 10.1007/s00125-015-3559-y. Epub 2015 Mar 14.

18.

Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes.

DiMeglio LA, Cheng P, Beck RW, Kollman C, Ruedy KJ, Slover R, Aye T, Weinzimer SA, Bremer AA, Buckingham B; Diabetes Research in Children Network (DirecNet); Type 1 Diabetes TrialNet Study Group.

Pediatr Diabetes. 2016 Jun;17(4):237-43. doi: 10.1111/pedi.12271. Epub 2015 Feb 27.

19.

A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.

Maahs DM, Calhoun P, Buckingham BA, Chase HP, Hramiak I, Lum J, Cameron F, Bequette BW, Aye T, Paul T, Slover R, Wadwa RP, Wilson DM, Kollman C, Beck RW; In Home Closed Loop Study Group.

Diabetes Care. 2014 Jul;37(7):1885-91. doi: 10.2337/dc13-2159. Epub 2014 May 7.

20.

The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes.

Maahs DM, Chase HP, Westfall E, Slover R, Huang S, Shin JJ, Kaufman FR, Pyle L, Snell-Bergeon JK.

Diabetes Technol Ther. 2014 May;16(5):284-91. doi: 10.1089/dia.2013.0227. Epub 2014 Jan 22.

PMID:
24450776
21.

Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study.

Garg SK, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR.

Diabetes Technol Ther. 2014 Mar;16(3):125-30. doi: 10.1089/dia.2013.0219. Epub 2014 Jan 9.

PMID:
24405492
22.

Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes.

Buckingham B, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA, DiMeglio LA, Bremer AA, Slover R, Tamborlane WV; Diabetes Research in Children Network (DirecNet) Study Group; Type 1 Diabetes TrialNet Study Group.

Diabetes Care. 2013 Dec;36(12):4030-5. doi: 10.2337/dc13-1074. Epub 2013 Oct 15.

23.

ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia.

Klonoff DC, Bergenstal RM, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann A, Welsh JB, Lee SW.

J Diabetes Sci Technol. 2013 Jul 1;7(4):1005-10.

24.

Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group.

N Engl J Med. 2013 Jul 18;369(3):224-32. doi: 10.1056/NEJMoa1303576. Epub 2013 Jun 22.

25.

The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis.

Diabetes Research in Children Network (DirecNet) Study Group; Type 1 Diabetes TrialNet Study Group, Buckingham BA, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA, DiMeglio LA, Bremer AA, Slover R, Cantwell M.

Diabetes Technol Ther. 2013 May;15(5):401-8. doi: 10.1089/dia.2013.0002. Epub 2013 Apr 9.

26.

Acceptability and utility of the mySentry remote glucose monitoring system.

Kaiserman K, Buckingham BA, Prakasam G, Gunville F, Slover RH, Wang Y, Nguyen X, Welsh JB.

J Diabetes Sci Technol. 2013 Mar 1;7(2):356-61.

27.

Continuous glucose monitoring in children and adolescents.

Slover RH 2nd.

Curr Diab Rep. 2012 Oct;12(5):510-6. doi: 10.1007/s11892-012-0303-6. Review.

PMID:
22791108
28.

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.

Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR.

Diabetes Technol Ther. 2012 Mar;14(3):205-9. doi: 10.1089/dia.2011.0292. Epub 2012 Feb 8.

PMID:
22316089
29.

The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.

Brazg RL, Bailey TS, Garg S, Buckingham BA, Slover RH, Klonoff DC, Nguyen X, Shin J, Welsh JB, Lee SW.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1466-71.

30.

Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study.

Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV.

Pediatr Diabetes. 2012 Feb;13(1):6-11. doi: 10.1111/j.1399-5448.2011.00793.x. Epub 2011 Jul 3.

PMID:
21722284
31.

Chronic pediatric pain.

Slover R, Neuenkirchen GL, Olamikan S, Kent S.

Adv Pediatr. 2010;57(1):141-62. doi: 10.1016/j.yapd.2010.08.009. Review. No abstract available.

PMID:
21056737
32.

Advances in the management of pain in children: acute pain.

Slover R, Coy J, Davids HR.

Adv Pediatr. 2009;56:341-58. doi: 10.1016/j.yapd.2009.08.016. Review. No abstract available.

PMID:
19968955
33.

Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes.

Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP.

Diabetes Technol Ther. 2007 Oct;9(5):421-8.

PMID:
17931050
34.

The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control.

Chase HP, Horner B, McFann K, Yetzer H, Gaston J, Banion C, Fiallo-Scharer R, Slover R, Klingensmith G.

Diabetes Care. 2006 May;29(5):1012-5.

PMID:
16644630
35.

Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up.

Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M; DAISY study.

Diabetes Care. 2004 Jun;27(6):1399-404.

PMID:
15161795
36.

Diabetic ketoacidosis with intracerebral complications.

Roberts MD, Slover RH, Chase HP.

Pediatr Diabetes. 2001 Sep;2(3):109-14.

PMID:
15016193
37.

Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy.

Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, Klingensmith GJ.

Pediatrics. 2004 Mar;113(3 Pt 1):e221-4.

PMID:
14993580
38.

Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care.

Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP.

Pediatrics. 2001 Feb;107(2):351-6.

PMID:
11158469
39.

Effectiveness of postprandial Humalog in toddlers with diabetes.

Rutledge KS, Chase HP, Klingensmith GJ, Walravens PA, Slover RH, Garg SK.

Pediatrics. 1997 Dec;100(6):968-72.

PMID:
9374566
40.

Prevention of type I diabetes and recurrent beta-cell destruction of transplanted islets.

Slover RH, Eisenbarth GS.

Endocr Rev. 1997 Apr;18(2):241-58. Review. No abstract available.

PMID:
9101139
41.

Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.

Sakkal-Alkaddour H, Zhang L, Yang X, Chang YT, Kappy M, Slover RS, Jorgensen V, Pang S.

J Clin Endocrinol Metab. 1996 Nov;81(11):3961-5.

PMID:
8923844
42.
43.

Epidural versus intravenous fentanyl: a problem with small sample size.

Slover R, Palmer SK.

Anesthesiology. 1991 Apr;74(4):795. No abstract available.

PMID:
2008964
44.

Accidental epidural cephazolin injection: safeguards for patient-controlled analgesia.

Kopacz DJ, Slover RB.

Anesthesiology. 1990 May;72(5):944-7. No abstract available.

PMID:
2339808
45.
46.

Blood phenylalanine estimation for the patient with phenylketonuria using a portable device.

Peterson K, Slover R, Gass S, Seltzer WK, McCabe LL, McCabe ER.

Biochem Med Metab Biol. 1988 Feb;39(1):98-104.

PMID:
3355720
47.

A comparison of clonidine and standard provocative agents of growth hormone.

Slover RH, Klingensmith GJ, Gotlin RW, Radcliffe J.

Am J Dis Child. 1984 Mar;138(3):314-7.

PMID:
6322574
48.

Frontonasal dysplasia with coronal craniosynostosis in three sibs.

Slover R, Sujansky E.

Birth Defects Orig Artic Ser. 1979;15(5B):75-83. No abstract available.

PMID:
526592

Supplemental Content

Loading ...
Support Center